Medicines and fundamental biology dominate cancer research in high-income countries

American Cancer Society

March 14, 2015 by Prof. Sullivan in ICP Reports

Cancer research spans all disciplines of science, from the social and humanistic to fundamental biomedicine. Cancer research in wealthy countries dominates disease-specific biomedical research. However, most research funding is skewed towards fundamental biology and treatment, particularly cancer medicines. While this has delivered an impressive amount of knowledge as well as new medicines and biomarkers, many parts of the world and areas of cancer research have been left behind. For example, prevention research attracts less than 5% of funding. Global cancer is challenged by a wide variety of issues, including sustainability, disincentives for research for the public good rather than for commercial benefit, and mismatch between funding and research need.

#
July 11, 2006
#
September 06, 2007
#
March 14, 2015
#
September 30, 2007
#
May 01, 2008
#
June 04, 2008
#
July 11, 2008
#
March 08, 2009
#
December 14, 2009
#
February 09, 2011
#
September 30, 2011
#
January 01, 2012
#
February 09, 2012
#
March 16, 2015
#
April 06, 2013
#
June 27, 2013
#
October 30, 2013
#
October 30, 2013
#
March 16, 2015
#
April 15, 2014
#
April 15, 2014
#
April 15, 2014
#
April 15, 2014
#
December 02, 2014
#
December 02, 2014
#
December 01, 2014
#
December 02, 2014
#
December 02, 2014
#
March 12, 2014
#
December 02, 2014
#
December 02, 2014
#
March 14, 2015